Su Kai, Wang Chunming
CSIRO Manufacturing Flagship, Bayview Avenue, Clayton, VIC, 3169, Australia.
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, N22-6011, Taipa, Macau, Special Administrative Region, People's Republic of China.
Biotechnol Lett. 2015 Nov;37(11):2139-45. doi: 10.1007/s10529-015-1907-0. Epub 2015 Jul 10.
The biomacromolecule, gelatin, has increasingly been used in biomedicine-beyond its traditional use in food and cosmetics. The appealing advantages of gelatin, such as its cell-adhesive structure, low cost, off-the-shelf availability, high biocompatibility, biodegradability and low immunogenicity, among others, have made it a desirable candidate for the development of biomaterials for tissue engineering and drug delivery. Gelatin can be formulated in the form of nanoparticles, employed as size-controllable porogen, adopted as surface coating agent and mixed with synthetic or natural biopolymers forming composite scaffolds. In this article, we review recent advances in the versatile applications of gelatin within biomedical context and attempt to draw upon its advantages and potential challenges.
生物大分子明胶,除了在食品和化妆品中的传统用途外,在生物医学领域的应用越来越广泛。明胶具有吸引人的优势,如细胞粘附结构、低成本、现货供应、高生物相容性、可生物降解性和低免疫原性等,这些使其成为组织工程和药物递送生物材料开发的理想候选者。明胶可以制成纳米颗粒的形式,用作尺寸可控的致孔剂,用作表面涂层剂,并与合成或天然生物聚合物混合形成复合支架。在本文中,我们综述了明胶在生物医学领域广泛应用的最新进展,并试图利用其优势和潜在挑战。